Gene Networks Constructed Through Simulated Treatment Learning can Predict Proteasome Inhibitor Benefit in Multiple Myeloma.

Joske UbelsPieter SonneveldMartin H van Vliet Jeroen de Ridder

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

STLsig can identify gene signatures that could aid in treatment decisions for patients with multiple myeloma and provide insight into the biological mechanism behind treatment benefit.

Keyphrases

multiple myeloma
genome wide
gene expression
copy number
combination therapy
genome wide identification